Natco Pharma Limited announced that the Board of Directors of the company at its meeting held on February 13, 2014, has considered and approved that Mr. Vivek Chhacchi, Nominee Director of CX Securities Ltd. and Mr. D. G. Prasad, Independent Director inducted as Additional Directors. Mr. Nitin Jagannath Deshmukh resigned as a Director due to his personal preoccupation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,000 INR | +0.27% | -1.95% | +23.29% |
05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.29% | 2.14B | |
+42.12% | 739B | |
+32.34% | 598B | |
-5.81% | 353B | |
+17.37% | 318B | |
+3.30% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.34% | 164B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Announces Board Changes